Gestational kynurenine metabolites mediate effects of pregnancy adiposity on child negative affect
Journal of Child Psychology and Psychiatry · 2025
DOI: 10.1111/jcpp.70071 ↗At a glance
Journal article in Journal of Child Psychology and Psychiatry, 2025. Written by Hanna C Gustafsson and 4 co-authors. Institution: Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA. Major MEDLINE topics: Kynurenine, Adiposity, Quinolinic Acid, Prenatal Exposure Delayed Effects. Cited 2 times so far (Crossref); 120 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIH HHS, NIMH NIH HHS, NCATS NIH HHS.
Abstract (original language)
Background
Mounting evidence links increased adiposity during pregnancy and offspring risk for mental health disorders. Yet the mechanisms underlying this association remain poorly understood, limiting our ability to design effective interventions. We hypothesize that alterations in the kynurenine system of the pregnant woman help to explain this association.
Methods
Participants were recruited during pregnancy with repeated assessments through 24 months postpartum. Maternal adiposity was assessed using air displacement plethysmography. Liquid chromatography tandem mass spectrometry was used to measure kynurenine system metabolites in maternal plasma. Child negative affect was assessed via maternal report at 6, 12, and 24 months.
Results
Participants ( N = 302) included mother–child dyads (70% non‐Hispanic White, 51% female). The ratio of picolinic to quinolinic acid (PA:QA) predicted child fear (β = −.15, 95% CI −0.27, −0.03, p = .02) and sadness (β = −.14, 95% CI −0.28, 0.003, p = .045) at 6 months. PA:QA mediated the effect of pregnancy adiposity on child fear (β = .03, bootstrapped 95% CI 0.009, 0.07) and sadness (β = .04, bootstrapped 95% CI 0.006, 0.08). Similar associations were observed when children were 12 and 24 months old, suggesting enduring effects. The ratio of kynurenic to quinolinic acid (KA:QA) was not associated with child negative affect.
Conclusions
This is the first evidence reporting that alterations in the kynurenine system during pregnancy are associated with increased child negative affectivity, an early life risk factor for psychopathology. Results further suggest that these kynurenine metabolites are a mechanistic link between pregnancy adiposity and child negative affect. Though observed effect sizes were small, results suggest that picolinic and quinolinic acid during pregnancy may be novel biomarkers for offspring behavioral risk.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.
- Steven J. Sharp Center for Mental Health Innovation, Oregon Health & Science University, Portland, OR, USA.
ORCID profiles: Hanna C Gustafsson, Joel T Nigg
Funding
- NIH HHS
- NIMH NIH HHS
- NCATS NIH HHS
- National Institute of Mental Health
- National Institutes of Health
- National Center for Advancing Translational Sciences
Cite
APA
Gustafsson, H. C., Wright, H. R., Schreeder, J. E. J., Nigg, J. T., & Sullivan, E. L. (2025). Gestational kynurenine metabolites mediate effects of pregnancy adiposity on child negative affect. Journal of Child Psychology and Psychiatry. https://doi.org/10.1111/jcpp.70071
Vancouver
Gustafsson HC, Wright HR, Schreeder JEJ, Nigg JT, Sullivan EL. Gestational kynurenine metabolites mediate effects of pregnancy adiposity on child negative affect. Journal of Child Psychology and Psychiatry. 2025. doi:10.1111/jcpp.70071
BibTeX
@article{Gustafsson2025,
author = {Gustafsson, Hanna C and Wright, Hanna R and Schreeder, Jorden E Jacinto and Nigg, Joel T and Sullivan, Elinor L},
title = {Gestational kynurenine metabolites mediate effects of pregnancy adiposity on child negative affect},
journal = {Journal of Child Psychology and Psychiatry},
year = {2025},
doi = {10.1111/jcpp.70071}
}
EUVIMED